Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide

Clinical trial NCT07713992 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07713992
Sponsor: Tianjin Medical University
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus

Start date: 2026-09-15
Primary completion: 2027-12-31
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.